Semaglutide and similar peptide drugs bind the G-protein coupled GLP-1 receptor to transfer chemical signals from outside the ...

MASLD has become the most common chronic liver disease worldwide. The authors review the features of the disease as well as ...

More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...

Research suggests Ozempic may weaken muscles even when they don’t shrink, with most lean mass loss coming from organ size ...

Tirzepatide (GIP + GLP-1) has also been shown to reduce cardiovascular risk. In an international trial of 713 adults in nine ...

Just like there are good and bad fats to eat, there are also good and bad types of fats to carry in the body. There's ...

Ozempic’s weight loss benefits might come at the cost of muscle strength, even if muscle size remains relatively stable. This ...

Are weight loss shots like Ozempic and Wegovy safe long-term? It’s complicated. Some early studies suggest thyroid concerns ...

Doctors are exploring an old, affordable diabetes drug as a possible way to help prevent dementia using real-world data from ...

A new study in mice has found that muscle loss associated with weight loss from GLP-1 medications like Ozempic may not be as ...

As announced July 29, Novo Nordisk NVO saw 18% sales growth and 40% operating profit growth at constant currencies in the second quarter. However, management reduced 2025 growth guidance for sales (8% ...

Novo Nordisk A/S (NYSE:NVO) on Wednesday reported second-quarter 2025 sales of roughly $11.68 billion (76.86 billion Danish ...